AlphaFold predicted structure
NDUFB7 · P17568

Mean pLDDT
88.1/ 100
Confident
137 residues
Confidence breakdown
- Very high(≥ 90)70%
- Confident(70–90)20%
- Low(50–70)6%
- Very low(< 50)4%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
NADH:ubiquinone oxidoreductase subunit B7
Annotations refreshed 10 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
BIALLELIC, autosomal or pseudoautosomalLikely inborn error of metabolism
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorder with complex I deficiency
BIALLELIC, autosomal or pseudoautosomalMitochondrial disorders
BIALLELIC, autosomal or pseudoautosomalPossible mitochondrial disorder - nuclear genes
BIALLELIC, autosomal or pseudoautosomalDDG2P
BIALLELIC, autosomal or pseudoautosomalmitochondrial complex I deficiency, nuclear type 39
type 2 diabetes mellitus
diabetes mellitus
Parkinson disease
neurodegenerative disease
multiple sclerosis
lysosomal storage disease
Alzheimer disease
polycystic ovary syndrome
gestational diabetes
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7
Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Complex I functions in the transfer of electrons from NADH to the respiratory chain. The immediate electron acceptor for the enzyme is believed to be ubiquinone
NDUFB7 · P17568

Mean pLDDT
88.1/ 100
Confident
137 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0